DUCTAL CARCINOMA IN SITU
Clinical trials for DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop breast cancer before it starts
Disease control Not yet recruitingThis early-phase trial tests a drug called CAN1012 in 24 people with pre-cancerous breast conditions (DCIS or LCIS). The drug is injected directly into the lesion to activate the immune system. The main goal is to check safety and ensure the treatment doesn't delay necessary surg…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a single day of radiation replace weeks of treatment for breast cancer?
Disease control Not yet recruitingThe SASHA trial is testing whether a single, high-dose radiation treatment delivered directly to the tumor site over one day is safe and effective for women with early-stage breast cancer. The study will enroll 134 women aged 40-85 who have already had a lumpectomy. Researchers w…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New keyhole breast cancer surgery could offer better looks, same safety
Disease control Not yet recruitingThis study tests a new type of breast-conserving surgery that uses a small camera inserted through a hidden armpit incision to remove tumors, compared to the standard open approach. About 1,366 women with early-stage breast cancer will be randomly assigned to one of the two surge…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Du Zhenggui • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New scanner aims to measure breast tumors more accurately
Diagnosis Not yet recruitingThis study will test if a new type of MRI scanner, called Field-Cycling Imaging (FCI), can accurately measure the size of breast tumors in people with ductal carcinoma in situ (DCIS). Twelve participants will receive both a standard MRI and an FCI scan before surgery. The results…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: University of Aberdeen • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Could a 'Baby Dose' of hormone pills prevent breast cancer?
Prevention Not yet recruitingThis study tests whether low doses of two hormone-blocking drugs, exemestane and tamoxifen, can help prevent breast cancer in postmenopausal women at high risk. About 140 women will take one of the two drugs for a year, and researchers will measure side effects and quality of lif…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Which workout wins for breast cancer recovery? a trial puts cardio vs conditioning to the test
Symptom relief Not yet recruitingThis study tests whether two different exercise programs—one combining resistance training with cardio, the other with conditioning—have similar effects on muscle mass, fat mass, and blood pressure in women who have completed breast cancer treatment. Participants will exercise th…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Aug 02, 2026 00:00 UTC
-
Could a Post-Workout protein shake help breast cancer survivors rebuild muscle?
Symptom relief Not yet recruitingThis study tests whether taking a high dose of whey protein after each workout helps breast cancer survivors gain more muscle and lose more fat compared to exercise alone. Participants are women aged 20 to 89 who have completed treatment for breast cancer and are prescribed exerc…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New scanner could halve repeat breast cancer surgeries
Symptom relief Not yet recruitingThis study tests a special scanner that lets surgeons check, in real time during breast cancer surgery, whether all cancer has been removed. The goal is to reduce the need for a second operation. About 228 women with certain high-risk breast cancer types will take part. The scann…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Hôpital du Valais • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Robot-Assisted mastectomy: could it mean less pain and faster healing?
Symptom relief Not yet recruitingThis study compares two types of nipple-sparing mastectomy: one done with a robotic arm through a small side incision, and the standard open surgery. Researchers want to see if the robotic method improves women's satisfaction, body image, and recovery over 12 months. The trial wi…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Beaumont Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Exercise after breast cancer: which workout best boosts healing muscle signals?
Knowledge-focused Not yet recruitingThis pilot study looks at how different resistance training routines change levels of myokines—molecules released by muscles during exercise—in women who have finished breast cancer treatment. Participants will be assigned to one of three exercise regimens (conditioning, strength…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Breast reconstruction study tests expanders beyond approved use
Knowledge-focused Not yet recruitingThis study will compare two different tissue expanders used in breast reconstruction after mastectomy in 80 women. Some participants will also receive radiation therapy, which is not typically recommended with these devices. Researchers will evaluate aesthetic outcomes, patient s…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Medical University Innsbruck • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC